{"schema_version":"secwatch.filing_event.v1","accession":"0001651308-24-000157","form_type":"8-K","ticker":"ONC","cik":"0001651308","company_name":"BeOne Medicines Ltd.","filed_at":"2024-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.111604+00:00","generated_at":"2026-05-29T22:31:20.420694+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BeiGene settles BRUKINSA patent litigation; generic entry no earlier than June 15, 2037","bullets":["Settlement with MSN allows generic BRUKINSA in U.S. no earlier than June 15, 2037, subject to customary accelerations.","Composition of matter patent expiring April 2034 was not challenged by MSN in the litigation.","Patent litigation against Sandoz also dismissed; all ANDA suits for BRUKINSA now resolved.","Parties filed joint stipulation to dismiss; settlement submitted to FTC and DOJ for review."],"urls":{"canonical":"https://secwatch.observer/filing/0001651308-24-000157","json":"https://secwatch.observer/filing/0001651308-24-000157.json","markdown":"https://secwatch.observer/filing/0001651308-24-000157.md","text":"https://secwatch.observer/filing/0001651308-24-000157.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000157/0001651308-24-000157-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000157/bgne-20241114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T22:31:20.420694+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}